A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
A resource hub for all things Premier.
Find what you’re looking for, fast! Select a category or topic to get to what matters to you most.
Premier joined 31 organizations in asking Congress for federal investments to support the pediatric physician workforce and access to care for the nation’s children.
Watch this on-demand webinar to learn more about the BPCI Advanced model, including recent changes, and what applicants should consider.
Premier weighs in on CMS' proposed rule to adopt standards for data transactions to support electronic prior authorization and healthcare claims transmission processes.
Premier provided feedback to the Senate Health, Education, Labor and Pensions Committee around pressing healthcare workforce issues and potential legislative solutions.
Premier reflects on the lessons learned during recent pandemic response efforts and provides Congress with detailed recommendations to address critical national security threats.
Supply Chain Brain | Premier's David Hargraves discusses lessons learned and actions needed for the industry to achieve true resilience and reliability.
Premier submitted comments on the Substance Abuse and Mental Health Services Administration proposed rule on medications for the treatment of opioid use disorder.
Premier weighed in on proposals to advance interoperability and improve prior authorization processes across CMS-regulated health programs.
Premier submitted comments to the U.S. Department of the Interior on the potential risk of supply disruptions for helium.
Axios | PINC AI™ data highlights the impacts of opioid use disorder, including costs, state variation and disparities among patients.
Premier joined eight other national hospital organizations in urging Congressional leaders to stop the reductions to the Medicaid disproportionate share hospital (DSH) program.
Healthcare Innovation | Could a pharmaceutical manufacturing site rating system lead to unintended consequences that exacerbate drug shortages?